Detalhe da pesquisa
1.
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
Eur Heart J
; 40(10): 842-853, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496390
2.
Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome.
Front Cardiovasc Med
; 9: 916036, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911527
3.
Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.
Int J Cardiol Heart Vasc
; 40: 101001, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35391783
4.
Electro-mechanical (dys-)function in long QT syndrome type 1.
Int J Cardiol
; 274: 144-151, 2019 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30017522
5.
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.
PLoS One
; 9(9): e107210, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25244401
6.
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
Heart Rhythm
; 10(10): 1533-41, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23892340